Patents by Inventor Stephen M. Spinella
Stephen M. Spinella has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11530304Abstract: A biofabricated material comprising a network of crosslinked collagen fibrils produced from recombinant collagen that contains substantially no 3-hydroxyproline residues is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability.Type: GrantFiled: February 15, 2017Date of Patent: December 20, 2022Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella, Katherine Amy Congdon
-
Patent number: 11214844Abstract: The invention herein provides biofabricated materials having zonal properties and methods of making biofabricated materials having zonal properties.Type: GrantFiled: November 13, 2018Date of Patent: January 4, 2022Assignee: Modern Meadow, Inc.Inventors: Brendan Patrick Purcell, Suzanne Lee, Lixin Dai, Katherine Amy Congdon, Stephen M. Spinella, Chi Man Ng
-
Patent number: 11001679Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: GrantFiled: March 19, 2019Date of Patent: May 11, 2021Assignee: Modern Meadow, Inc.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella
-
Patent number: 10370504Abstract: Described herein is a method for producing a biofabricated material from collagen or collagen-like proteins which are recombinantly produced and which contain substantially no 3-hydroxyproline. The collagen or collagen-like proteins are isolated from animal sources, or produced by recombinant DNA techniques or by chemical synthesis. The collagen or collagen-like proteins are fibrillated, crosslinked, dehydrated and lubricated thus forming the biofabricated material having a substantially uniform network of collagen fibrils.Type: GrantFiled: February 15, 2017Date of Patent: August 6, 2019Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Francoise Suzanne Marga, Susan J. Schofer, Darryl Miles Cassingham, Stephen M. Spinella, Amy Congdon
-
Publication number: 20190203000Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: ApplicationFiled: March 19, 2019Publication date: July 4, 2019Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Lixin DAI, Darryl Miles CASSINGHAM, Stephen M. SPINELLA
-
Patent number: 10301440Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: GrantFiled: February 15, 2017Date of Patent: May 28, 2019Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella
-
Publication number: 20190144957Abstract: The invention herein provides biofabricated materials having zonal properties and methods of making biofabricated materials having zonal properties.Type: ApplicationFiled: November 13, 2018Publication date: May 16, 2019Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, Suzanne LEE, Lixin DAI, Katherine Amy CONGDON, Stephen M. SPINELLA, Chi Man NG
-
Publication number: 20170233838Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: ApplicationFiled: February 15, 2017Publication date: August 17, 2017Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Lixin DAI, Darryl Miles CASSINGHAM, Stephen M. SPINELLA
-
Publication number: 20170233834Abstract: Described herein is a method for producing a biofabricated material from collagen or collagen-like proteins which are recombinantly produced and which contain substantially no 3-hydroxyproline. The collagen or collagen-like proteins are isolated from animal sources, or produced by recombinant DNA techniques or by chemical synthesis. The collagen or collagen-like proteins are fibrillated, crosslinked, dehydrated and lubricated thus forming the biofabricated material having a substantially uniform network of collagen fibrils.Type: ApplicationFiled: February 15, 2017Publication date: August 17, 2017Applicant: MODERN MEADOW, INCInventors: Brendan Patrick PURCELL, David Thomas Williamson, Francoise Suzanne Marga, Susan J. Schofer, Darryl Miles Cassingham, Stephen M. Spinella, Amy Congdon
-
Publication number: 20170233944Abstract: A biofabricated material comprising a network of crosslinked collagen fibrils produced from recombinant collagen that contains substantially no 3-hydroxyproline residues is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability.Type: ApplicationFiled: February 15, 2017Publication date: August 17, 2017Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Lixin DAI, Darryl Miles CASSINGHAM, Stephen M. SPINELLA, Amy CONGDON